المؤلفون: Wildiers, H., Dirix, L., Neven, P., Prové, A., Clement, P., Squifflet, P., Amant, F., Skacel, T., Paridaens, R.

المساهمون: Multidisciplinary Breast Center, University Hospitals Leuven Leuven, Department of General Medical Oncology Leuven, Multidisciplinary Breast Centre, University Hospital Gasthuisberg, Department of Medical Oncology, St-Augustinus, IDDI, Medical Affairs, Amgen (Europe) GmbH, Department of Medicine, Charles University Prague (CU)

المصدر: ISSN: 0167-6806.

مصطلحات موضوعية: Breast cancer, Chemotherapy, Cyclophosphamide, Docetaxel, Dose densification, Epirubicin, Fluorouracil, Granulocyte colony-stimulating factor, Pegfilgrastim, Relative dose intensity

العلاقة: hal-00478329; https://hal.archives-ouvertes.fr/hal-00478329Test; https://hal.archives-ouvertes.fr/hal-00478329/documentTest; https://hal.archives-ouvertes.fr/hal-00478329/file/PEER_stage2_10.1007%252Fs10549-008-9970-z.pdfTest

الإتاحة: https://doi.org/10.1007/s10549-008-9970-zTest
https://hal.archives-ouvertes.fr/hal-00478329Test
https://hal.archives-ouvertes.fr/hal-00478329/documentTest
https://hal.archives-ouvertes.fr/hal-00478329/file/PEER_stage2_10.1007%252Fs10549-008-9970-z.pdfTest

المؤلفون: Nikitas, N., Karadimou, A., Tsitoura, E., Soupos, N., Tsiatas, M., Karavasilis, V., Pectasides, Dimitrios, Pavlidis, Nicholas, Chrisofos, M., Adamakis, I., Murray, S., Fountzilas, George, Dimopoulos, M. A., Bamias, A. T.

المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Karavasilis, V. [0000-0002-5806-9399]

المصدر: Pharmacogenomics

مصطلحات موضوعية: Male, Oncology, Genetic association studies, Messenger rna, medicine.medical_treatment, Kaplan-Meier Estimate, Biomarkers, Pharmacological, Carboplatin, chemistry.chemical_compound, Cancer specific survival, Genotype, Urothelial cancer, Treatment outcome, Single nucleotide, Middle aged, Survival time, Single-nucleotide polymorphism, Platinum derivative, Genetic analysis, Homozygote, Urogenital tract cancer, Human ercc1 gene, Middle Aged, Excision repair cross complementing protein 1, Polymerase chain reaction, Urologic neoplasms, DNA-Binding Proteins, Treatment Outcome, Molecular Medicine, Female, Cancer chemotherapy, Restriction fragment length polymorphism, Human, medicine.drug, Adult, Heterozygote, Urologic Neoplasms, medicine.medical_specialty, Disease-free survival, Drug response, Major clinical study, Biology, Vinblastine, Polymorphism, Single Nucleotide, Article, Disease-Free Survival, Dose densification, Advanced cancer, Internal medicine, Genetics, medicine, Humans, Polymorphism, Genotyping, Genetic Association Studies, Aged, Neoplasm Staging, Platinum, Gene amplification, Pharmacology, Cisplatin, Cancer prognosis, Chemotherapy, Pharmacological, Dna, Kaplan-meier estimate, Endonucleases, Gemcitabine, Gene frequency, Dna-binding proteins, Single nucleotide polymorphism, Nucleotide excision repair, Methotrexate, chemistry, Doxorubicin, Ercc1 gene, Pharmacogenetics, Neoplasm staging, Genetic association, Cancer patient, Progression free survival, ERCC1, Biomarkers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bfc0cb1987b72088a3d20615db03225Test
https://doi.org/10.2217/pgs.12.162Test

المؤلفون: L Dirix, Pierre Squifflet, T. Skacel, Paul Clement, A Prové, Robert Paridaens, Frédéric Amant, Patrick Neven, Hans Wildiers

المساهمون: Multidisciplinary Breast Center, University Hospitals Leuven [Leuven], Department of General Medical Oncology [Leuven], Multidisciplinary Breast Centre, University Hospital Gasthuisberg, Department of Medical Oncology, St-Augustinus, IDDI, Medical Affairs, Amgen (Europe) GmbH, Department of Medicine, Charles University [Prague] (CU), Other departments

المصدر: Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2008, 114 (1), pp.103-112. ⟨10.1007/s10549-008-9970-z⟩
Breast cancer research and treatment, 114(1), 103-112. Springer New York
Breast cancer research and treatment

مصطلحات موضوعية: Oncology, Adult, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Breast Neoplasms, Docetaxel, Drug Administration Schedule, 03 medical and health sciences, Dose densification, Granulocyte colony-stimulating factor, 0302 clinical medicine, Breast cancer, Breast cancer chemotherapy, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Chemotherapy, 030212 general & internal medicine, Relative dose intensity, Cyclophosphamide, Epirubicin, Dose-Response Relationship, Drug, business.industry, Middle Aged, medicine.disease, Pegfilgrastim, 3. Good health, Surgery, Tolerability, Fluorouracil, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Feasibility Studies, Female, Taxoids, Human medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3f0b4d3cb887b57d35c85beb939824fTest
https://hal.archives-ouvertes.fr/hal-00478329Test

مصطلحات موضوعية: Breast cancer, Chemotherapy, Cyclophosphamide, Docetaxel, Dose densification, Epirubicin, Fluorouracil, Granulocyte colony-stimulating factor, Pegfilgrastim, Relative dose intensity

العلاقة: 0167-6806 (pISSN); 1573-7217 (eISSN); 10549 (JournalID); s10549-008-9970-z (publisherID); 9970 (ArticleID); http://hdl.handle.net/2262/42241Test; Breast Cancer Research and Treatment; 114; 103; 112

الإتاحة: https://doi.org/10.1007/s10549-008-9970-zTest
http://hdl.handle.net/2262/42241Test